(72) demonstrated that serum leptin levels were related to overall breast cancer risk (standardized mean difference = 0.46, 95% CI 0.31-0.60), especially in Chinese women (standardized mean difference = 0.61, 95% CI 0.44-0.79). This evidence concerns the gene LEP and breast carcinoma.